In diffuse cutaneous systemic sclerosis, which autoantibody is most characteristic?

Prepare for the Internal Medicine II Test with engaging flashcards and multiple-choice questions. Each question is detailed with hints and explanations. Gear up your knowledge for success!

Multiple Choice

In diffuse cutaneous systemic sclerosis, which autoantibody is most characteristic?

Explanation:
Autoantibody profiles in systemic sclerosis help distinguish disease subsets and prognosis. Anti-Scl-70 (topoisomerase I) is most characteristic of diffuse cutaneous systemic sclerosis, and its presence is linked to more extensive skin involvement and a higher risk of interstitial lung disease. In contrast, anticentromere antibodies are more typical of the limited form (CREST) with milder internal organ disease. Anti-RNP antibodies point to mixed connective tissue disease, and anti-DNA antibodies are more typical of systemic lupus erythematosus. Thus, the antibody most characteristic of diffuse cutaneous systemic sclerosis is anti-Scl-70.

Autoantibody profiles in systemic sclerosis help distinguish disease subsets and prognosis. Anti-Scl-70 (topoisomerase I) is most characteristic of diffuse cutaneous systemic sclerosis, and its presence is linked to more extensive skin involvement and a higher risk of interstitial lung disease. In contrast, anticentromere antibodies are more typical of the limited form (CREST) with milder internal organ disease. Anti-RNP antibodies point to mixed connective tissue disease, and anti-DNA antibodies are more typical of systemic lupus erythematosus. Thus, the antibody most characteristic of diffuse cutaneous systemic sclerosis is anti-Scl-70.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy